Neurexis Therapeutics

Neurexis Therapeutics

San Diego, United States· Est. 2018

Neuroprotective Innovationfor Human Health Surviving a brain disorder is only half the battle. For millions of patients, long-lasting cognitive impairment reshapes daily life. This persistent damage is driven by neurodegeneration, a shared hallmark across major disorders of the central nervous system, including global cerebral ischemia, spinal cord ischemia, stroke, and Alzheimer’s disease.Despite tremendous effort, there

Private Company

Total funding raised: $5M

About

Neuroprotective Innovationfor Human Health Surviving a brain disorder is only half the battle. For millions of patients, long-lasting cognitive impairment reshapes daily life. This persistent damage is driven by neurodegeneration, a shared hallmark across major disorders of the central nervous system, including global cerebral ischemia, spinal cord ischemia, stroke, and Alzheimer’s disease.Despite tremendous effort, there

RNA & Gene Therapy

Funding History

1
Total raised:$5M
Seed$5MJun 15, 2022